Dengue Hemorrhagic Fever (DHF) is a severe and potentially life-threatening complication of dengue virus infection characterized by plasma leakage, bleeding tendencies, and dangerously low platelet counts. It most commonly occurs during secondary infections when a person is infected with a different dengue virus strain after having been infected with another strain previously. The Dengue Fever Antibodies (IgG, IgM) test is the most important test for DHF diagnosis because it identifies both current infection and previous exposure, helping determine if this is a high-risk secondary infection.
90-day money-back guarantee
Lab order in minutes
Save a trip to the doctor
Low prices since 2005
Labs within 2 miles
Dengue Hemorrhagic Fever is caused by a secondary infection with a different strain of the dengue virus (serotypes DEN-1, DEN-2, DEN-3, or DEN-4) after previous infection with another dengue strain. When antibodies from the first infection encounter a different dengue strain, they trigger antibody-dependent enhancement, a process where pre-existing antibodies actually help the virus enter immune cells and replicate more aggressively. This immune system complication leads to severe symptoms including plasma leakage, internal bleeding, and critically low platelet counts that characterize DHF.
The Dengue Fever Antibodies (IgG, IgM) test is the most important test for Dengue Hemorrhagic Fever because it detects both current infection (IgM antibodies) and previous dengue exposure (IgG antibodies). High levels of IgG combined with IgM indicate a secondary dengue infection, which is the primary risk factor for developing DHF. This test is essential for identifying patients at highest risk, as secondary infections are 15-80 times more likely to progress to severe DHF compared to first-time dengue infections. Additional tests like complete blood count (CBC) to monitor platelet levels and hematocrit are also important for tracking disease progression and plasma leakage.
You should get tested immediately if you develop symptoms within 3-14 days after traveling to dengue-endemic areas (Southeast Asia, Latin America, Caribbean, Pacific Islands) and experience high fever, severe headache, pain behind the eyes, joint and muscle pain, or rash. Testing becomes critical if you have had dengue fever before, as secondary infections dramatically increase DHF risk. Seek emergency testing if you develop warning signs like severe abdominal pain, persistent vomiting, bleeding from nose or gums, blood in vomit or stool, difficulty breathing, or extreme fatigue, as these indicate progression to DHF requiring immediate hospitalization.
Save a trip to the doctor, go directly to the lab
Instant orders, results often overnight*
Results explained in simple language
Reviewed by US licensed doctors
Fast & confidential, we never sell or share your data
No insurance needed, transparent pricing
What this means
Your test came back negative for dengue IgM antibodies, meaning no evidence of recent or current dengue infection was detected. This is the expected and healthy result if you have not been recently infected with dengue virus.
Recommended actions
Use EPA-registered insect repellent containing DEET when traveling to tropical regions
Wear long sleeves and pants in dengue-endemic areas, especially during dawn and dusk
Eliminate standing water around your home to prevent mosquito breeding
Consider retesting if you develop fever and joint pain after mosquito exposure
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
3303 reviews
Sample results
Your 24/7 Personal Lab Guide
Quick questions:
